Elkem ASA announced an agreement to sell the majority of its Silicones division to Bluestar in a transaction settled through the redemption of Bluestar’s 52.9 percent equity stake in Elkem, eliminating Bluestar as a shareholder. The deal leaves Elkem fully controlled by minority investors and refocuses the listed group on metals and materials with a simpler balance sheet, lower capital intensity, and a reset ownership structure.
The transaction, expected to close by May 2026 subject to shareholder and lender approvals, represents the culmination of a strategic review that began in early 2025 and addresses both portfolio focus and long-standing ownership complexity.
Why Elkem ASA is unwinding its Silicones ownership now after a prolonged strategic review
The decision to divest control of the Silicones division reflects a recognition that Elkem’s portfolio had become strategically stretched across businesses with different capital intensity, cyclicality, and competitive dynamics. Silicones, while structurally attractive in parts of the value chain, carries higher volatility and requires a different investment and operating rhythm than Elkem’s silicon products and carbon solutions businesses.
By separating control of Silicones, Elkem is simplifying its industrial logic. Management is prioritising segments where captive raw material access, energy optimisation, and process integration drive sustainable margins rather than exposure to downstream demand swings and pricing cycles that are harder to hedge.
Timing also matters. The transaction comes at a point when Elkem is preparing for refinancing and balance-sheet recalibration. Removing Silicones reduces operational complexity precisely as capital markets remain selective on industrial leverage and cash flow durability.
How the Bluestar share redemption structure reshapes Elkem ASA’s ownership without cash changing hands
Unlike a conventional sale, the transaction is settled entirely through the redemption of Bluestar’s 338.3 million shares in Elkem, representing 52.9 percent of the company. No cash payments are exchanged between the parties, making the deal as much an ownership reset as a portfolio divestment.
Post-closing, Bluestar will no longer hold any shares in Elkem, and minority shareholders will assume 100 percent control of the listed entity. This structure eliminates a controlling shareholder dynamic that had implications for governance, capital allocation expectations, and investor perception.
For Elkem, the benefit is clarity. Governance becomes fully aligned with public market norms, and future strategic decisions no longer need to be assessed through the lens of a dominant industrial shareholder with parallel interests in the silicones value chain.
What Bluestar gains strategically by taking control of the Silicones assets outright
Bluestar’s rationale is equally strategic. As a former owner of parts of the Silicones assets and a long-term participant in the silicones value chain, Bluestar brings industrial familiarity and vertical ambitions that are better suited to a privately controlled platform.
Full operational control allows Bluestar to pursue integration, capital deployment, and specialisation strategies that would have been constrained within a listed conglomerate structure. With APAC as the largest market within the Silicones perimeter, Bluestar is positioned to align capacity, sourcing, and downstream positioning with regional growth priorities.
The deal effectively reunites assets with an owner whose strategic horizon is defined by industrial scale rather than quarterly market scrutiny.
Which Silicones assets Elkem ASA is retaining and why they still matter strategically
Elkem is retaining selected upstream and downstream Silicones-related assets, including Yongdeng in China, Roussillon in France, and Chakan in India. These retained assets are not accidental leftovers but reflect strategic optionality.
At Roussillon, Elkem has secured a five-year supply agreement for upstream silicones to the downstream business being transferred to Bluestar and to a third party, designed to keep operations economically viable and earnings neutral. This preserves industrial continuity while avoiding exposure to downstream volatility.
For the remaining retained assets, Elkem is actively exploring strategic alternatives, signalling that further portfolio refinement remains on the table rather than a hard stop.
How the transaction changes Elkem ASA’s financial profile and capital intensity
Following completion, Elkem will operate through Silicon Products, Carbon Solutions, and Other, with materially lower capital intensity than the pre-transaction group. This shift is central to the strategic logic.
Lower capital intensity improves free cash flow generation, enhances deleveraging capacity, and provides greater flexibility in capital allocation. Management has been explicit that the goal is a more attractive over-the-cycle financial profile with reduced earnings volatility.
Net interest-bearing debt is estimated at approximately NOK 9.8 billion immediately after the transaction, excluding the contemplated equity raise. While leverage remains meaningful, the earnings mix supporting that debt will be structurally different and, in management’s view, more resilient.
Why Elkem ASA is pairing the Silicones divestment with a NOK 1.5 billion equity raise
In parallel with the transaction, Elkem intends to raise NOK 1.5 billion in new equity capital, fully underwritten by Folketrygdfondet, Must Invest, DNB Asset Management, Nordea Investment Management, and Perestroika. These investors have also pre-committed support for the transaction at the extraordinary general meeting.
The equity raise serves multiple purposes. It strengthens the balance sheet ahead of refinancing discussions, supports investment grade credit ambitions based on mid-cycle earnings capacity, and provides dry powder for selective organic and inorganic growth.
Importantly, the underwriting by long-term institutional investors signals confidence in the post-transaction strategy rather than opportunistic capital raising.
What governance changes follow once Bluestar exits the shareholder register
Upon closing, Bluestar representatives will resign from Elkem’s board of directors and nomination committee, and new board members will be elected at the extraordinary general meeting. This marks a clean governance break.
For institutional investors, the shift removes potential conflicts between controlling shareholder interests and minority shareholders. Board composition and strategic oversight will now be fully aligned with the interests of the public float.
The independent board has obtained a fairness opinion from DNB Carnegie, concluding that the transaction is financially fair from the perspective of shareholders other than Bluestar, adding a procedural safeguard to the governance transition.
How investors are likely to interpret Elkem ASA’s strategic pivot and ownership reset
Market reaction is likely to hinge less on short-term earnings impact and more on strategic coherence. Investors generally reward industrial simplification when it improves transparency, cash flow predictability, and governance clarity.
The absence of cash proceeds may initially confuse some observers, but the elimination of a controlling shareholder and the reset capital structure address issues that often weigh on valuation multiples. Over time, the investment case shifts toward disciplined capital allocation and selective growth rather than portfolio sprawl.
Institutional backing for both the transaction and the equity raise suggests that long-term shareholders view the move as value-protective rather than dilutive.
What this deal signals about broader trends in the European materials sector
Elkem’s transaction reflects a broader European industrial trend toward focus, balance-sheet resilience, and governance simplification. Conglomerate structures that once promised diversification are increasingly being reassessed as capital markets favour clarity and strategic coherence.
The deal also highlights a growing willingness to use non-cash mechanisms, such as share redemptions and ownership restructuring, to solve strategic constraints when conventional divestments fall short.
For peers across metals, materials, and specialty chemicals, Elkem’s approach offers a case study in how to realign strategy without destabilising operations.
What Elkem ASA’s Silicones divestment and Bluestar exit mean for investors and the materials industry
- Elkem ASA is using the Silicones divestment to resolve a long-standing ownership complexity rather than to generate immediate cash.
- The redemption of Bluestar’s 52.9 percent stake leaves Elkem fully controlled by minority shareholders, improving governance clarity.
- Post-transaction, Elkem becomes a more focused metals and materials group with lower capital intensity and reduced earnings volatility.
- The absence of cash consideration is offset by balance-sheet strengthening through a NOK 1.5 billion fully underwritten equity raise.
- Institutional investor backing signals confidence in the post-transaction strategy and financial profile.
- Bluestar gains full control of Silicones assets aligned with its industrial and regional priorities, particularly in APAC.
- Retained Silicones-related assets preserve strategic optionality rather than representing stranded businesses.
- Governance changes following Bluestar’s exit are likely to be viewed positively by public market investors.
- The transaction reflects a wider European trend toward portfolio simplification and capital discipline.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
